Fusion Spatial Biology Event

A Fusion of Technologies, Disciplines, and Knowledge

Original Air Date: February 17, 2022

Join us for glimpse into future of spatial biology, featuring thought leaders, innovators, and industry experts who will discuss the latest developments in the field and share their insights on how a fusion of technologies, disciplines, and knowledge is redefining spatial phenotyping and biomarker discovery. 


Why Fusion?

Catalyzing the Revolution in Spatial Biology with Fusion
Learn about the fusion of core technologies, disciplines, and knowledge that is driving transformative change in the field of spatial biology


leadership Brian McKelligon

Brian McKelligon

Chief Executive Officer,
Akoya Biosciences

Brian joined Akoya Biosciences in July 2017 serving as the CEO, bringing his experience as a 25-year veteran of the life sciences market with a proven track record of building and commercializing products and services for both the research and clinical markets. Most recently, he drove corporate and business development at Cellular Dynamics International (acquired by FUJIFilm) with a focus on the development and partnering of their four cell therapy programs. Prior to that, Brian built and ran commercial organizations at 10X Genomics, Thermo Fisher Scientific / Life Technologies, Affymetrix (IPO, acquired by Thermo Fisher) and Ingenuity Systems (acquired by Qiagen). He came to Thermo Fisher and Life Technologies through their acquisition of Ion Torrent in 2010 where he was an early employee and built the global commercial organization.

A Fusion of Technologies

Introducing Spatial Biology 2.0
See how Akoya’s new PhenoCycler™-Fusion system will fuel spatial discovery and translational research with rapid, whole-slide imaging to reveal new insights into tissue architecture and cellular function


niro ramachandran 160x160 1

Niro Ramachandran, PhD

Chief Business Officer,
Akoya Biosciences

Niro joined Akoya in August 2020 to serve as the Chief Business Officer responsible for developing a robust roadmap and commercialization strategy for Akoya’s platforms. Niro has nearly two decades of experience in developing and commercializing products in the life science market. He has commercialized over 30 products across genomics and proteomics research markets. More recently, he served as the vice president of the spatial biology business unit at Nanostring Technologies (2014 – 2020). Prior to this, Niro led product development for the protein business unit at Life Technologies (2008-2014; acquired by Thermo Fisher). Niro received his Hon. BSc in Biochemistry from University of Toronto, and PhD from University of Windsor. He completed his post doctorate work at the Harvard Institute of Proteomics, Harvard University.

A Fusion of Disciplines

Discovering the Rules of Cancer via Tissue Schematics
Explore the frontiers of spatial biology to learn about revolutionary computational approaches for reverse-engineering tissues from high-parameter imaging data to develop predictive models for cancers


leadership Gary Nolan

Garry Nolan, PhD

The Rachford and Carlota A. Harris Professor in the Department of Microbiology and Immunology
Stanford University School of Medicine

A co-inventor of the CODEX technology and co-founder of Akoya Biosciences, Garry is a spatial biology pioneer, who has focused his research efforts on developing novel technologies and computational methods for research into cancer, leukemia, immunology and autoimmune disease. Garry was the founder of a number of life sciences companies in addition to Akoya, including Rigel Inc. (NASDAQ: RIGL) and DVS Sciences and serves as an advisor and board member for several biotechnology companies. He trained with Leonard Herzenberg (for his Ph.D.) and Nobelist Dr. David Baltimore. He has published over 220 research articles and is the holder of 20 US patents, and has been honored as one of the top 25 inventors at Stanford University. Garry is the first recipient of the Teal Innovator Award (2012) from the Department of Defense and has been honored with a number of awards including Nature Publishing “Outstanding Research Achievement”, Stohlman Scholar from the Leukemia and Lymphoma Society and Burroughs Wellcome Fund New Investigator Award.

A Fusion of Knowledge

Developing Spatial Phenotypic Signatures to Evaluate Response to Immunotherapies
Learn how spatial biology can uncover the interactions of immune cell subsets in immunotherapy-treated samples, yielding predictive spatial signatures to differentiate responders and non-responders


Padmanee Sharma

Padmanee Sharma, MD, PhD

Professor of Genitourinary Medical Oncology and Immunology,
MD Anderson Cancer Center

Padmanee is a leading figure in oncology, specializing in renal, bladder and prostate cancer. An immunologist and oncologist, she is currently professor of genitourinary medical oncology and immunology in the Division of Cancer Medicine. Her primary focus is to understand the mechanisms and pathways within the immune system responsible for tumor rejection. Since 2005 she has been a principal investigator for several clinical trials launched to improve the efficacy of cancer immunotherapies.

A Fusion of Applications

Mapping the Future of Biology
Gain insights into the spatial biology approaches for analyzing patient sample and understanding disease, using a unique set of biological mapping tools and a cloud-based bioinformatics pipeline, to guide researchers, drug developers and physicians toward the goal of better medicine.


Aaron Mayer 160

Aaron Mayer, PhD

Chief Scientific Officer,
Enable Medicine

Aaron is co-founder and CSO at Enable Medicine, a venture backed team of biological and software engineers.  He received his PhD in Bioengineering from Stanford University, where he developed molecular imaging tools, including novel software, hardware, and biological wetware, to improve monitoring of cancer immunotherapies in the clinic. At Enable Medicine, Aaron and his team are mapping the future of biology by developing cartography tools that enable researchers, drug developers, and physicians to explore disease at the cellular level, navigate patient care, and discover new drugs.

Sign up to Watch Presentations On-demand

Sponsored by:    akoya logo standard color            enable logo black